153 related articles for article (PubMed ID: 17325908)
21. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab.
Seewoodhary J
World J Gastroenterol; 2006 Dec; 12(45):7391. PubMed ID: 17143963
[TBL] [Abstract][Full Text] [Related]
23. Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.
Cook RC; Connors JM; Gascoyne RD; Fradet G; Levy RD
Lancet; 1999 Nov; 354(9191):1698-9. PubMed ID: 10568575
[TBL] [Abstract][Full Text] [Related]
24. Rituximab in diffuse large B-cell lymphoma.
Coiffier B
Clin Adv Hematol Oncol; 2004 Mar; 2(3):156-7. PubMed ID: 16166943
[No Abstract] [Full Text] [Related]
25. [Epstein-Barr virus-related B-cell lymphoma of the skin which developed early after cord blood transplantation for angioimmunoblastic T-cell lymphoma].
Tajika K; Tamai H; Mizuki T; Nakayama K; Yamaguchi H; Dan K
Rinsho Ketsueki; 2010 Feb; 51(2):138-42. PubMed ID: 20379106
[TBL] [Abstract][Full Text] [Related]
26. [A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia].
Kubota Y
Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):453-7. PubMed ID: 16841717
[TBL] [Abstract][Full Text] [Related]
27. Secondary Cutaneous Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma with Hodgkin/Reed-Sternberg-like Cells in a Patient with Angioimmunoblastic T-cell Lymphoma.
Chen H; Xue YN; Xin CM; Xiong JS; Ni X; Sun JF
Acta Derm Venereol; 2018 Nov; 98(10):981-982. PubMed ID: 29956714
[No Abstract] [Full Text] [Related]
28. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
[TBL] [Abstract][Full Text] [Related]
29. T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation.
Narumi H; Kojima K; Matsuo Y; Shikata H; Sekiya K; Niiya T; Bando S; Niiya H; Azuma T; Yakushijin Y; Sakai I; Yasukawa M; Fujita S
Bone Marrow Transplant; 2004 Jan; 33(1):99-101. PubMed ID: 14704662
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
Lenz G; Golf A; Rüdiger T; Hiddemann W; Haferlach T
Blood; 2003 Nov; 102(9):3457-8. PubMed ID: 14568909
[No Abstract] [Full Text] [Related]
31. Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome.
Sano T; Sakai H; Takimoto K; Ohno H
Int J Clin Oncol; 2007 Feb; 12(1):59-62. PubMed ID: 17380444
[TBL] [Abstract][Full Text] [Related]
32. Treatment of lympho-proliferative disease with rituximab.
Niedermeyer J; Hoffmeyer F; Hertenstein B; Hoeper MM; Fabel H
Lancet; 2000 Feb; 355(9202):499. PubMed ID: 10841158
[No Abstract] [Full Text] [Related]
33. Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients.
Jenkins D; DiFrancesco L; Chaudhry A; Morris D; Glück S; Jones A; Woodman R; Brown CB; Russell J; Stewart DA
Bone Marrow Transplant; 2002 Sep; 30(5):321-6. PubMed ID: 12209355
[TBL] [Abstract][Full Text] [Related]
34. Independent growth of diffuse large B cell lymphoma and angioimmunoblastic T cell lymphoma originating from composite lymphoma.
Tabata R; Tabata C; Yasumizu R; Kojima M
Ann Hematol; 2014 Oct; 93(10):1801-3. PubMed ID: 24488225
[No Abstract] [Full Text] [Related]
35. Effective in vivo purging with rituximab and autologous peripheral blood stem cell transplantation in a woman with CD5 positive primary cutaneous diffuse large B-cell lymphoma.
Goto H; Nishio M; Endo T; Sato N; Koizumi K; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
Eur J Haematol; 2005 Jun; 74(6):526-8. PubMed ID: 15876258
[TBL] [Abstract][Full Text] [Related]
36. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM
Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432
[TBL] [Abstract][Full Text] [Related]
37. Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Arnason JE; Luptakova K; Rosenblatt J; Tzachanis D; Avigan D; Zwicker JI; Levine J; Kim M; Parker JA; Grant B; Joyce RM
Acta Haematol; 2015; 133(4):347-53. PubMed ID: 25677780
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
Alizadeh AA; Advani RH
Clin Adv Hematol Oncol; 2008 Dec; 6(12):899-909. PubMed ID: 19209140
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
40. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
Racila E; Link BK; Weng WK; Witzig TE; Ansell S; Maurer MJ; Huang J; Dahle C; Halwani A; Levy R; Weiner GJ
Clin Cancer Res; 2008 Oct; 14(20):6697-703. PubMed ID: 18927313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
